iSAM Funds (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
iSAM Funds (UK)'s VRTX Position: Q3 2026 in Review
iSAM Funds (UK) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 2,080 shares — an estimated $1.03M sold.
iSAM Funds (UK) first reported a position in VRTX in Q1 2024 and held it in 6 quarters. The position peaked at $1.46M in Q4 2025. 1,775 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- iSAM Funds (UK) reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- iSAM Funds (UK) sold 2,080 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.03M.
- iSAM Funds (UK) first reported a position in Vertex Pharmaceuticals in Q1 2024 and held it in 6 quarters.
- iSAM Funds (UK)'s Vertex Pharmaceuticals position peaked at $1.46M in Q4 2025.
- 1,775 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on iSAM Funds (UK)'s 13F filing for Q3 2026, filed 16 Nov 2026.